sur NEOVACS (EPA:ALNEV)
NEOVACS: Update of share capital and voting rights
On July 8, 2025, NEOVACS, a biopharmaceutical company focused on developing treatments for inflammatory and autoimmune diseases, announced the number of shares and voting rights constituting its share capital. As of June 30, 2025, the company announced 476,625,693 shares and an equivalent number of voting rights, both gross and net.
Since January 2025, NEOVACS has issued new shares every month, generated mainly by conversions of OCEANE and ORA. As of June 2025, the number of shares issued was 268,545,608. Additional information is available on the NEOVACS website.
Recent financings through OCEANE-BSA and ORA may put downward pressure on the share price. Investors are encouraged to exercise caution regarding these dilutive transactions.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NEOVACS